Edgewise Therapeutics Inc (NASDAQ: EWTX) kicked off on Friday, up 7.83% from the previous trading day, before settling in for the closing price of $14.89. Over the past 52 weeks, EWTX has traded in a range of $10.60-$38.12.
A company in the Healthcare sector has dropped its sales by -49.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -10.95%. With a float of $74.60 million, this company’s outstanding shares have now reached $105.34 million.
Edgewise Therapeutics Inc (EWTX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Edgewise Therapeutics Inc is 29.18%, while institutional ownership is 84.46%. The most recent insider transaction that took place on Aug 26 ’25, was worth 1,459,760. In this transaction Chief Scientific Officer of this company sold 100,000 shares at a rate of $14.60, taking the stock ownership to the 23,400 shares. Before that another transaction happened on Aug 26 ’25, when Company’s Officer proposed sale 100,000 for $14.60, making the entire transaction worth $1,459,760.
Edgewise Therapeutics Inc (EWTX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.36 earnings per share (EPS), higher than consensus estimate (set at -0.37) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.41% during the next five years compared to -49.00% drop over the previous five years of trading.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Take a look at Edgewise Therapeutics Inc’s (EWTX) current performance indicators. Last quarter, stock had a quick ratio of 28.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.93 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.18 million. That was inferior than the volume of 1.19 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.56%.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 80.41%, which indicates a significant increase from 71.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.98 in the past 14 days, which was higher than the 0.76 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.30, while its 200-day Moving Average is $19.08. However, in the short run, Edgewise Therapeutics Inc’s stock first resistance to watch stands at $16.83. Second resistance stands at $17.61. The third major resistance level sits at $18.69. If the price goes on to break the first support level at $14.97, it is likely to go to the next support level at $13.89. The third support level lies at $13.11 if the price breaches the second support level.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
The company with the Market Capitalisation of 1.69 billion has total of 105,346K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -133,810 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -36,120 K.
